Bio-Rad Laboratories Inc (NYSE:BIO) (TREND ANALYSIS) shares were traded with thin volume. The stock closed last trading session at $144.71, down by -2.98%, with a volume of 112,575 shares against an average volume for the last 3 months of 139,391.
Bio-Rad Laboratories, Inc. (NYSE:BIO) has lost 2.21% during the past week and dropped 8.32% in the last 4 weeks. The shares have outperformed the S&P 500 by 1.23% in the past week but underperformed the index by 0.86% in the last 4 weeks.
An investigation on behalf of investors of Bio-Rad Laboratories, Inc. (NYSE:BIO) shares over potential securities laws violations by Bio-Rad Laboratories and certain of its directors and officers in connection certain financial statements was announced.